Ledger.Open graph →
SEC Form D · Amendment · filed August 4, 2014

Scilex Pharmaceuticals Inc

Offering
$5.3M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MALVERN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Jonathan N. Heiliger · Menlo Park, CAExec · DirectorRichard B. Cohen · Malvern, PAExecMarcus L. Collins · Chicago, ILDirectorJonathan M. Mohrhardt · Chicago, ILExec · DirectorIn Sik N. Rhee · Menlo Park, CAExec · DirectorSiobhan C. Foy · Walnut Creek, CADirectorWells Capital Management Incorporated · San Francisco, CAExec · DirectorCraig J. Paddock · Lawrence, KSDirectorAnn Marie Scheidt · STONY BROOK, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗